GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

Protagonist is directly going up against Eli Lilly, which is advancing retatrutide, also a triple-G agonist, in a Phase II ...

The UK's medicines regulator has launched a study to investigate the impact of these drugs following reports of people dying ...

Hundreds of people have reported problems with their pancreas linked to taking weight loss and diabetes jabs, prompting ...

While Novo Nordisk stock has underperformed since my Strong Buy rating four months ago, the long-term investment thesis ...

The Fidelity MSCI Health Care Index ETF (FHLC) was launched on 10/21/2013, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Broad segment of the ...